$NCNA

NuCana plc

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$0.6205 -

Last Close

VOLUME

66,719

DAY RANGE

0.62 - 0.8

52 WEEK

0.5171 - 3.32

Join Discuss about NCNA with like-minded investors

profile
@maletone #StockTraders.NET
recently

will decide if I swing some or not like $NCNA

76 Replies 13 👍 15 🔥

profile
@TraderXx #StockTraders.NET
recently

if $NCNA builds at or above 2.80's, will be a long IMO

120 Replies 9 👍 15 🔥

profile
@TraderXx #StockTraders.NET
recently

am very suspicious about $NCNA

107 Replies 15 👍 8 🔥

profile
@TraderXx #StockTraders.NET
recently

hmm, it looks like someone positioned them selfs in it, walked it down, and then in coming days or next week will leg up again > @maletone said: I'm all covered $NCNA but 1 share to just see where it ultimately goes

143 Replies 9 👍 15 🔥

profile
@maletone #StockTraders.NET
recently

I'm all covered $NCNA but 1 share to just see where it ultimately goes

87 Replies 15 👍 13 🔥

profile
@maletone #StockTraders.NET
recently

watchlist for tomorrow: $DATS, $PALT, $CEI, $NCNA, $GROM

88 Replies 9 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

covered some $NCNA

78 Replies 11 👍 15 🔥

profile
@maletone #StockTraders.NET
recently

will cover the rest of $NCNA in the .60s

75 Replies 12 👍 13 🔥

profile
@Chano #StockTraders.NET
recently

$NCNA ultimate support here...

107 Replies 15 👍 13 🔥

profile
@Chano #StockTraders.NET
recently

I saw a stall and covered 5 minutes earlier in 2.95s damn! > @maletone said: covered some $NCNA

133 Replies 15 👍 9 🔥

profile
@maletone #StockTraders.NET
recently

covered some $NCNA

48 Replies 10 👍 11 🔥

profile
@maletone #StockTraders.NET
recently

covered some $NCNA

86 Replies 15 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

$NCNA needs to take out $3

117 Replies 10 👍 9 🔥

profile
@maletone #StockTraders.NET
recently

watching $NCNA

147 Replies 11 👍 10 🔥

profile
@maletone #StockTraders.NET
recently

might be interested in $NCNA short at $4+

46 Replies 12 👍 15 🔥

Key Metrics

Market Cap

32.38 M

Beta

1.46

Avg. Volume

94.42 K

Shares Outstanding

52.18 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-18

Next Dividend Date

Company Information

NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying its ProTide technology to transform some of the most widely prescribed chemotherapy agents, nucleoside analogs, into more effective and safer medicines. While these conventional agents remain part of the standard of care for the treatment of many solid and hematological tumors, their efficacy is limited by cancer cell resistance mechanisms and they are often poorly tolerated. Utilizing its proprietary technology, the company is developing new medicines, ProTides, designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. NuCana's robust pipeline includes three ProTides in clinical development. Acelarin and NUC-3373, are new chemical entities derived from the nucleoside analogs gemcitabine and 5-fluorouracil, respectively, two widely used chemotherapy agents. Acelarin is in a Phase III study for patients with advanced biliary tract cancer and a Phase III study for patients with metastatic pancreatic cancer for which enrollment has been suspended. NUC-3373 is in a Phase I study for the potential treatment of a wide range of patients with advanced solid tumors and a Phase Ib study for patients with metastatic colorectal cancer. Its third ProTide, NUC-7738, is a transformation of a novel nucleoside analog (3'-deoxyadenosine) and is in a Phase I study for patients with advanced solid tumors.

CEO: Hugh Griffith

Website:

HQ: Lochside House 3 Lochside Way, EH12 9DT Edinburgh

Related News